Creative Diagnostics has launched the Norovirus VP1 VLP Panel, a new research tool designed to support the study of norovirus ...

The most recent updates show the number of people suffering norovirus in England has risen to a record high, with many people ...

Creative Diagnostics announces the launch of its new Norovirus VP1 VLP Panel to support NoV research. NEW YORK, NY, UNITED STATES, February ...

The presence of one oligosaccharide, called the H1-antigen, is required for attachment by many norovirus strains. People who do not make H1-antigen in their intestinal cells make up 20% of the ...

Norovirus (NoV) protruding (P ... antibody that blocks NoV virus-like particle binding to the histo-blood group antigen receptors, and therefore it is a promising candidate vaccine against ...

Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...

In addition, analysts are bullish on the company due to Moderna, Inc.’s (NASDAQ:MRNA) non-respiratory portfolio, which includes vaccines for norovirus and cytomegalovirus (CMV). mRNA-4157 ...

Here’s how to protect yourself from norovirus, COVID-19 ... for marketing outside of emergency use. Most use rapid antigen technology, meaning the test can identify a particular component ...